plaque psoriasis Archives - Express Pharma

Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara

Janssen’s JNJ-2113 holds potential to become leading treatment for psoriasis: GlobalData

EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData

Novartis secures approval in China for Cosentyx

Unichem Laboratories gets USFDA approval for Apremilast Tablets

Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis

Sun Pharma declares five-year positive results for ILUMYA (tildrakizumab-asmn)

Sun Pharma launches ILUMYA (tildrakizumab) in Japan

Sun Pharma receives Japan MHLW approval of ILUMYATM for the treatment of Plaque Psoriasis

Sun Pharma presents insights into clinical use of ILUMYA in moderate-to-severe plaque psoriasis